Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results-Reference-Cited by-同舟云学术

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

Published:2013-02 Issue:2 Volume:24 Page:398-405
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Coleman R.,de Boer R.,Eidtmann H.,Llombart A.,Davidson N.,Neven P.,von Minckwitz G.,Sleeboom H.P.,Forbes J.,Barrios C.,Frassoldati A.,Campbell I.,Paija O.,Martin N.,Modi A.,Bundred N.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/2/398/13788575/mds277.pdf

Reference23 articles.

1. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Aebi;Ann Oncol,2010

2. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer;Burstein;J Clin Oncol,2010

3. Survival and safety of exemestane versus tamoxifen after 2–3 years’ tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial;Coombes;Lancet,2007

4. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial;Cuzick;Lancet Oncol,2010

5. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen;Goss;J Clin Oncol,2008

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer treatment-induced bone loss;The Korean Journal of Internal Medicine;2024-09-01

2. Drug assumption and awareness about adverse drug reactions. The right to know. The case of the bone-modyfing agents: a systematic review;Frontiers in Oral Health;2024-08-01

3. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-07-09

4. Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial;Journal of Clinical Oncology;2024-07-02

5. Approach to Bone Health in the Patient With Breast Cancer;The Journal of Clinical Endocrinology & Metabolism;2024-06-12